J. Phillips

发表

Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studies.

S. L. Yates, C. Tedford, G. Pawlowski, 1995, The Journal of pharmacology and experimental therapeutics.

Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.

S. L. Yates, W. Hirth, C. Tedford, 1999, Journal of medicinal chemistry.

Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands.

S. L. Yates, L. Fadnis, C. Tedford, 1999, The Journal of pharmacology and experimental therapeutics.

Deficits in neuronal cytochrome P450 activity attenuate opioid analgesia but not opioid side effects.

Xinxin Ding, Weizhu Yang, C. Fang, 2014, European journal of pharmacology.

CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist

I. D. Esch, R. Stadel, M. Wentland, 2007, Neuropharmacology.

Antinociceptive activity of chemical congeners of improgan: Optimization of side chain length leads to the discovery of a new, potent, non-opioid analgesic

R. Leurs, K. Svokos, I. D. Esch, 2006, Neuropharmacology.

A route to stereochemically complex tetrahydrofurans using α-sulfinyl carbanions

David R. Williams, J. Phillips, 1986 .

Chapter 4 – Recent Advances in Histamine H3 Receptor Agents

S. L. Yates, S. M. Ali, C. Tedford, 1998 .

Development of a sensitive and quantitative analytical method for 1H-4-substituted imidazole histamine H3-receptor antagonists utilizing high-performance liquid chromatography and dabsyl derivatization.

W. Hirth, L. Fadnis, C. Tedford, 1998, Journal of chromatography. B, Biomedical sciences and applications.

Cytochrome P450 2C24: Expression, Tissue Distribution, High-Throughput Assay, and Pharmacological Inhibition.

M. Wentland, L. Hough, J. Phillips, 2012, Acta pharmaceutica Sinica. B.

3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.

S. Davidsen, M. Bures, G. Sheppard, 1994, Journal of medicinal chemistry.

Total synthesis of milbemycin .beta.3

David R. Williams, J. Phillips, K. Nishitani, 1982 .

Antinociceptive activity of CC44, a biotinylated improgan congener.

Paul Hoerbelt, M. Wentland, J. Nalwalk, 2013, European journal of pharmacology.

Neuropharmacology and analgesia Antinociceptive activity of CC 44 , a biotinylated improgan congener

Paul Hoerbelt, M. Wentland, J. Nalwalk, 2013 .

Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.

S. L. Yates, L. Fadnis, C. Tedford, 1999, The Journal of pharmacology and experimental therapeutics.

New acetylene based histamine H3 receptor antagonists derived from the marine natural product verongamine.

S. L. Yates, C. Tedford, J. Phillips, 1998, Bioorganic & medicinal chemistry letters.

Medicinal chemistry of histamine H3 receptor antagonists

S. M. Ali, J. Phillips, 1998 .

High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models.

S. L. Yates, R. Levi, C. Tedford, 1998, European journal of pharmacology.

Studies of stereochemical control using α-lithiosulfinyl carbanions

David R. Williams, F. H. White, J. Huffman, 1986 .

A synthesis of the juvabiols

David R. Williams, J. Phillips, 1981 .

A stereospecific synthesis of highly substituted tetrahydrofurans

David R. Williams, J. Phillips, B. A. Barner, 1981 .

1-[2′-(trimethylsilyl)ethoxymethyl]-2-phenylsulfonylimidazole: A new reagent for the preparation of C-4 substituted imidazoles

David R. Williams, L. Fadnis, J. Phillips, 1997 .

A Practical Synthesis of 1-N-SEM-Protected3-Iodo-7-methyl-2-piperidin-3-ylindole

W. Lew, J. Phillips, M. Jaworska, 2010 .

Addressing the malaria drug resistance challenge using flow cytometry to discover new antimalarials.

P. Zimmerman, B. Grimberg, L. Hough, 2009, Bioorganic & medicinal chemistry letters.

Stereoselective approach to acyclic systems via condensations of .alpha.-lithiosulfinyl carbanions and aldehydes

David R. Williams, J. Huffman, J. Phillips, 1981 .

Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic

O. Zuiderveld, R. Leurs, J. Bidlack, 2011, PAIN®.

Diastereoselective synthesis of trans-2-(1-triphenylmethyl-1H-imidazol-4-yl)cyclopropanecarboxylic acids: key intermediates for the preparation of potent and chiral histamine H3 receptor agents

S. L. Yates, K. Kirschbaum, C. Tedford, 1997 .

Diastereoselective Synthesis of trans‐2‐(1‐Triphenylmethyl‐1H‐imidazol‐4‐yl)cyclopropanecarboxylic Acids: Key Intermediates for the Preparation of Potent and Chiral Histamine H3 Receptor Agents.

S. L. Yates, K. Kirschbaum, C. Tedford, 1998 .

Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D Inhibitors.

James Delproposto, J. Stuckey, Krishnapriya Chinnaswamy, 2016, ACS medicinal chemistry letters.

High-Affinity Binding of [3H]Cimetidine to a Heme-Containing Protein in Rat Brain

R. Stadel, J. Nalwalk, L. Hough, 2008, Drug Metabolism and Disposition.

CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociception

J. Nalwalk, L. Hough, J. Phillips, 2013, Brain Research.